Pulike Biological Engineering, Inc. (SHA:603566)

China flag China · Delayed Price · Currency is CNY
12.60
-0.27 (-2.10%)
Apr 17, 2026, 1:34 PM CST
Market Cap4.40B +4.0%
Revenue (ttm)1.10B +1.7%
Net Income143.67M +41.3%
EPS0.42 +43.4%
Shares Out341.92M
PE Ratio30.71
Forward PE22.78
Dividend0.40 (3.11%)
Ex-Dividend DateOct 17, 2025
Volume3,098,964
Average Volume4,326,622
Open12.88
Previous Close12.87
Day's Range12.55 - 12.90
52-Week Range11.80 - 15.79
Beta0.54
RSI49.77
Earnings DateApr 29, 2026

About SHA:603566

Pulike Biological Engineering, Inc. engages in the research, development, production, and sale of veterinary biological products, chemical drugs, and traditional Chinese veterinary drugs. The company offers vaccines, antibodies, and medicines for swine and poultry, as well as disinfectants. Pulike Biological Engineering, Inc. was founded in 1995 and is headquartered in Luoyang, China. [Read more]

Industry Biotechnology
Sector Healthcare
Founded 1995
Employees 1,551
Stock Exchange Shanghai Stock Exchange
Ticker Symbol 603566
Full Company Profile

Financial Performance

In 2024, SHA:603566's revenue was 1.04 billion, a decrease of -16.77% compared to the previous year's 1.25 billion. Earnings were 92.81 million, a decrease of -46.82%.

Financial Statements